- About us
- Our people
- Our expertise
- Strategic IP
- Practice groups
- Case studies
- Knowledge bank
- Contact us
31 May 2019
Partner, Adrian Tombling explores why AI is huge for drug research and what impact this could have on the pharmaceutical industry.
As AI is created by a computer, it does raise the question, who owns the IP? In this second video, Adrian answers this exact question.
Life Sciences & Chemistry Group
If you require further information on anything covered in this briefing, please contact Adrian Tombling (email@example.com; +49 89 50222 4020) or your usual contact at the firm. This video is a general summary of the law. It should not replace legal advice tailored to your specific circumstances.
© Withers & Rogers LLP, May 2019